Abstract:Background: Recent study has proved the feasibility of transforming fibroblasts to excitable cells by means of gene engineering; dermal fibroblasts is the most abundant seed cells in organism. Objective: To investigate the effects of dermal fibroblasts transfected by both myogenic determination and connexin 43 genes on B-type natriuretic peptide (BNP) and myocardial infarction (MI) size by its function of transplantation in situ at the lesioned sites in acute MI rats. Design, time and setting: Randomized control experiments were carried out in the Cell Treatment Centre, East Hospital Affiliated to Tongji University and Experimental Animal Center of Shanghai University of Traditional Chinese Medicine (Shanghai, China) from June 2006 to March 2007. Materials: Sixty male Sprague-Dawley rats were randomly divided into four groups (n=15): normal control group, MI control group, normal transplantation group and MI transplantation group. Methods: MI model was established by ligating left coronary artery anterior descending branch in rats. Four weeks later, thoracotomy was performed to conduct myocardial cell transplantation in situ. Dermal fibroblasts were converted by both myogenic determination and connexin 43 genes, then were labeled with bromodeoxyuridine. The prepared cell suspension, 100 mL containing 1.0×106 cells, was transplanted into the juncture between MI area and unlesioned area. Ischemic myocardium from surrounding cardiac apex, interventricular septum and left ventricular anterior lateral wall was also transplanted with 100 μ L cell suspension, with the injector depth of 4 mm. In the control groups, DMEM cell liquid without cells were given. Main outcome measures: Before cell transplantation and 1 day, 1 week, 2 weeks, 4 weeks after cell transplantation, plasma BNP concentrations were detected. Heart rate, arterial blood pressure, left ventricular pressure, isovolumic contractive and diastolic function (left ventricular pressure maximal rate of rise and fall) were determined. MI size was measured in 4 weeks after cell transplantation using immunocytochemistry staining. Results: Immunocytochemistry results demonstrated the expression of bromodeoxyuridine in the myocardial scar area. Cell transplantation could significantly improve the hemodynamics in MI rats. Plasma BNP concentrations in the MI control group and the MI transplantation group were obviously higher than those in the normal control group and the normal transplantation group (P < 0.01). At 1 day, 1 week and 2 weeks after transplantation, there were no significant differences in the plasma BNP concentration between MI transplantation group and MI control group, but the concentration in the MI transplantation group was remarkably reduced 4 weeks later (P <0.01). MI size in the MI transplantation group was significantly smaller than those in the MI control group (P <0.01). Conclusion: In situ transplantation of dermal fibroblasts converted by both myogenic determination and connexin 43, can repair necrotic myocardium tissue and decrease the MI size.

Regeneration of the myocardium: a new role in the treatment of ischemic heart disease?

Reprogramming Autologous Skeletal Myoblasts to Express Cardiomyogenic Function. Challenges and Possible Approaches.

New Perspectives in the Treatment of Damaged Myocardium Using Autologous Skeletal Myoblasts

Effect of myocardial transplantation after myogenic determination and connexin 43 genes transfected into dermal fibroblasts on B-type natriuretic peptide and infarcted size in rats with myocardial infarction

Myocardial regeneration: present and future trends

Cardiac-bio-assists: Biological Approaches to Support or Repair Cardiac Muscle.

Cellular Cardiomyoplasty: a Preliminary Clinical Report.

Leading Progress in Heart Regeneration and Repair

Hybrid techniques for myocardial regeneration: state of the art and future perspectives

STEM CELL PLASTICITY: REGENERATION OF FUNCTIONAL MYOCARDIUM FROM BONE MARROW STEM CELLS (BMSC).

Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction

New treatment methods for myocardial infarction

Bone marrow cells regenerate infarcted myocardium

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Possible Muscle Repair in the Human Cardiovascular System

Acquired control over proliferation and differentiation of ventricular cardiomyocytes to break down the mechanisms of cardiac repair

Combining Pharmacological Mobilization with Intramyocardial Delivery of Bone Marrow Cells Over-Expressing VEGF is More Effective for Cardiac Repair.

Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction.

Transplantation of Nanoparticle Transfected Skeletal Myoblasts Overexpressing Vascular Endothelial Growth Factor-165 for Cardiac Repair

Graft of cardiac progenitors in a pig model of right ventricular failure triggers myocardial epimorphosis, regeneration and protection of function